<DOC>
	<DOCNO>NCT00005858</DOCNO>
	<brief_summary>Phase I trial study effectiveness LMB-9 immunotoxin treat patient advanced colon , breast , non-small cell lung , bladder , pancreatic , ovarian cancer . The LMB-9 immunotoxin locate tumor cell kill without harm normal cell .</brief_summary>
	<brief_title>LMB-9 Immunotoxin Treating Patients With Advanced Colon , Breast , Non-small Cell Lung , Bladder , Pancreatic , Ovarian Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose LMB-9 immunotoxin patient advance colon , breast , non-small cell lung , bladder , pancreas , ovarian cancer . II . Assess toxicity pharmacokinetics treatment regimen patient . III . Determine clinical response patient treat regimen . OUTLINE : This dose-escalation study . Patients receive LMB-9 immunotoxin IV continuously 10 day . Treatment continue every 30 day absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos LMB-9 immunotoxin maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 3 2 6 patient experience dose-limiting toxicity . Patients follow 3 week every 2 month thereafter .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Immunotoxins</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm advanced colon , breast , nonsmall cell lung , bladder , pancreas , ovarian cancer refractory standard treatment effective standard therapy exist Expresses Lewis Y antigen Evidence disease progression B3 antigen surface 30 % tumor cell determine immunohistochemistry No neutralizing antibody LMB9 immunotoxin No untreated CNS metastases PATIENT CHARACTERISTICS : Age : 18 Sex : Male female Performance status : ECOG 01 Life expectancy : At least 3 month Hematopoietic : Absolute granulocyte count great 1,200/mm^3 Platelet count great 100,000/mm^3 Hepatic : Bilirubin great 1.5 time normal SGOT SGPT great 2.5 time upper limit normal ( liver metastasis allow ) Albumin least 3.0 g/dL No prior liver disease ( e.g. , alcohol liver disease ) Hepatitis B C negative Renal : Creatinine great 1.4 mg/dL Creatinine clearance great 60 mL/min Proteinuria le 1 g/24 hour Cardiovascular : No history coronary artery disease No cardiac arrhythmia require therapy No New York Heart Association class IIIV congestive heart failure Pulmonary : Pulmonary function test require significant smoking history , possible pulmonary disease , lung cancer FEV1 FVC least 65 % predict Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No known seizure disorder No urinary tract infection No concurrent malignancy No active peptic ulcer disease No known allergy omeprazole No contraindication pressor therapy No concurrent medical psychological condition would preclude study PRIOR CONCURRENT THERAPY : Chemotherapy : At least 3 week since prior chemotherapy ( 6 week mitomycin nitrosoureas ) recover Endocrine therapy : At least 3 week since prior hormonal therapy Radiotherapy : At least 3 week since prior radiotherapy recover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>stage III bladder cancer</keyword>
	<keyword>recurrent bladder cancer</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>ovarian stromal cancer</keyword>
	<keyword>stage III ovarian germ cell tumor</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>borderline ovarian surface epithelial-stromal tumor</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>male breast cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>